J. Allen, T. Adrian, J. Polak, and S. Bloom, Neuropeptide Y (NPY) in the adrenal gland, Journal of the Autonomic Nervous System, vol.9, issue.2-3, pp.559-563, 1983.
DOI : 10.1016/0165-1838(83)90013-9

D. Autelitano, Cardiac Expression of Genes Encoding Putative Adrenomedullin/Calcitonin Gene-Related Peptide Receptors, Biochemical and Biophysical Research Communications, vol.250, issue.3, pp.689-693, 1998.
DOI : 10.1006/bbrc.1998.9375

D. Autelitano and F. Tang, Co-expression of prepro-adrenomedullin with a putative adrenomedullin receptor gene in vascular smooth muscle, Clinical Science, vol.96, issue.5, pp.493-498, 1999.
DOI : 10.1042/cs0960493

K. Babinski, V. Bodart, M. Roy, D. Lean, A. Ong et al., Pituitary adenylate-cyclase activating polypeptide (PACAP) evokes long-lasting secretion and de novo biosynthesis of bovine adrenal medullary neuropeptides, Neuropeptides, vol.30, issue.6, pp.572-582, 1996.
DOI : 10.1016/S0143-4179(96)90041-4

C. Bleul, M. Farzan, H. Choe, C. Parolin, I. Clark-lewis et al., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry, Nature, vol.382, issue.6594, pp.829-833, 1996.
DOI : 10.1038/382829a0

L. Breault, Y. L. Montero, M. Chouinard, L. Contesse, V. Delarue et al., Occurrence and Effect of PACAP in the Human Fetal Adrenal Gland, Annals of the New York Academy of Sciences, vol.83, issue.1, pp.429-433, 2000.
DOI : 10.1111/j.1749-6632.2000.tb07010.x

C. Cavadas, A. Silva, F. Mosimann, M. Cotrim, C. Ribeiro et al., NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.12, pp.5956-5963, 2001.
DOI : 10.1210/jcem.86.12.8091
URL : https://academic.oup.com/jcem/article-pdf/86/12/5956/9170222/jcem5956.pdf

C. Cavadas, D. Cefai, J. Rosmaninho-salgado, M. Vieira-coelho, E. Moura et al., Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion, Proceedings of the National Academy of Sciences, vol.114, issue.7, pp.10497-10502, 2006.
DOI : 10.1111/j.1476-5381.1995.tb13362.x

S. Cleary, J. Phillips, T. Huynh, K. Pacak, A. Elkahloun et al., Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome, Journal of Endocrinology, vol.193, issue.2, pp.225-233, 2007.
DOI : 10.1677/JOE-06-0138
URL : http://joe.endocrinology-journals.org/content/193/2/225.full.pdf

M. De-quidt and P. Emson, Neuropeptide Y in the adrenal gland: Characterisation, distribution and drug effects, Neuroscience, vol.19, issue.3, pp.1011-1022, 1986.
DOI : 10.1016/0306-4522(86)90313-1

A. Dejda, V. Jolivel, S. Bourgault, T. Seaborn, A. Fournier et al., , p.7637, 2008.

, in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases, J Mol Neurosci, vol.36, pp.26-37

P. Des-senanayake, J. Denker, E. Bravo, and R. Graham, Production, characterization, and expression of neuropeptide Y by human pheochromocytoma., Journal of Clinical Investigation, vol.96, issue.5, pp.2503-2509, 1995.
DOI : 10.1172/JCI118310

Y. Dumont and R. Quirion, An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization, EXS, vol.95, pp.7-33, 2006.
DOI : 10.1007/3-7643-7417-9_2

L. Edvinsson, P. Emson, J. Mcculloch, K. Tatemoto, and R. Uddman, Neuropeptide Y: Cerebrovascular innervation an vasomotor effects in the cat, Neuroscience Letters, vol.43, issue.1, pp.79-84, 1983.
DOI : 10.1016/0304-3940(83)90132-5

J. Fahrenkrug, T. Buhl, and H. J. , PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP, Regulatory Peptides, vol.58, issue.3, pp.89-98, 1995.
DOI : 10.1016/0167-0115(95)00052-D

S. Fetissov, J. Kopp, and T. Hokfelt, Distribution of NPY receptors in the hypothalamus, Neuropeptides, vol.38, issue.4, pp.175-188, 2004.
DOI : 10.1016/j.npep.2004.05.009

M. Garcia-fernandez, G. Bodega, A. Ruiz-villaespesa, J. Cortes, J. Prieto et al., PACAP expression and distribution in human breast cancer and healthy tissue, Cancer Letters, vol.205, issue.2, pp.189-195, 2004.
DOI : 10.1016/j.canlet.2003.10.008

H. Ghzili, L. Grumolato, E. Thouënnon, Y. Tanguy, V. Turquier et al., Role of PACAP in the physiology and pathology of the sympathoadrenal system, Frontiers in Neuroendocrinology, vol.29, issue.1, pp.128-141, 2008.
DOI : 10.1016/j.yfrne.2007.10.001

E. Grouzmann, C. Gicquel, P. Plouin, M. Schlumberger, E. Comoy et al., Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas, Cancer, vol.2, issue.8, pp.1833-1835, 1990.
DOI : 10.1002/1097-0142(19901015)66:8<1833::AID-CNCR2820660831>3.0.CO;2-9

L. Grumolato, E. Louiset, D. Alexandre, D. Ait-ali, V. Turquier et al., PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells, European Journal of Neuroscience, vol.93, issue.Suppl. 3, pp.71-82, 2003.
DOI : 10.1016/S0306-4522(99)00108-6

J. Guillemot, D. Ait-ali, V. Turquier, M. Montero-hadjadje, A. Fournier et al., Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells, Regulatory Peptides, vol.137, issue.1-2, pp.79-88, 2006.
DOI : 10.1016/j.regpep.2006.04.023

J. Guillemot, D. Ait-ali, V. Turquier, M. Montero-hadjadje, A. Fournier et al., PACAP Stimulates the Release of the Secretogranin II-Derived Peptide EM66 from Chromaffin Cells, Annals of the New York Academy of Sciences, vol.1070, issue.1, pp.309-312, 2006.
DOI : 10.1196/annals.1317.033

C. Hamelink, O. Tjurmina, R. Damadzic, W. Young, E. Weihe et al., Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis, Proceedings of the National Academy of Sciences, vol.39, issue.3, pp.461-466, 2002.
DOI : 10.1111/j.1471-4159.1988.tb01817.x
URL : http://www.pnas.org/content/99/1/461.full.pdf

D. Hansel, B. Eipper, and G. Ronnett, Neuropeptide Y functions as a neuroproliferative factor, Nature, vol.127, issue.6831, pp.940-944, 2001.
DOI : 10.1210/endo-127-1-133

A. Harmar, W. Sheward, C. Morrison, B. Waser, M. Gugger et al., Receptor in Peripheral Tissues of the Mouse, Endocrinology, vol.145, issue.3, pp.1203-1210, 2004.
DOI : 10.1210/en.2003-1058

T. Hexum and L. Russett, Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y, Neuropeptides, vol.13, issue.1, pp.35-41, 1989.
DOI : 10.1016/0143-4179(89)90019-X

M. Hong, S. Li, A. Fournier, S. St-pierre, and G. Pelletier, Role of Neuropeptide Y in the Regulation of Tyrosine Hydroxylase Gene Expression in Rat Adrenal Glands, Neuroendocrinology, vol.61, issue.1, pp.85-88, 1995.
DOI : 10.1159/000126816

K. Isobe, I. Tatsuno, T. Yashiro, T. Nanmoku, K. Takekoshi et al., Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis, Regulatory Peptides, vol.110, issue.3, pp.213-217, 2003.
DOI : 10.1016/S0167-0115(02)00209-4

K. Isobe, M. Kaneko, S. Kaneko, S. Nissato, T. Nanmoku et al., Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis, Regulatory Peptides, vol.123, issue.1-3, pp.29-32, 2004.
DOI : 10.1016/j.regpep.2004.05.011

K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura et al., Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma, Biochemical and Biophysical Research Communications, vol.192, issue.2, pp.553-560, 1993.
DOI : 10.1006/bbrc.1993.1451

J. Kitlinska, Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization, Cancer Letters, vol.245, issue.1-2, pp.293-302, 2007.
DOI : 10.1016/j.canlet.2006.01.010

J. Kitlinska, K. Abe, L. Kuo, J. Pons, M. Yu et al., Differential Effects of Neuropeptide Y on the Growth and Vascularization of Neural Crest???Derived Tumors, Cancer Research, vol.65, issue.5, pp.1719-1728, 2005.
DOI : 10.1158/0008-5472.CAN-04-2192

H. Kobayashi, R. Yamamoto, K. Kitamura, K. Kuwasako, S. Minami et al., Selective inhibition of nicotinic cholinergic receptors by proadrenomedullin N-terminal 12 peptide in bovine adrenal chromaffin cells, Molecular Brain Research, vol.87, issue.2, pp.175-183, 2001.
DOI : 10.1016/S0169-328X(01)00011-0

H. Kobayashi, T. Yanagita, H. Yokoo, and A. Wada, Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) in adrenal chromaffin cells, Peptides, vol.22, issue.11, pp.1895-1901, 2001.
DOI : 10.1016/S0196-9781(01)00512-5

H. Kobayashi, T. Yanagita, H. Yokoo, and A. Wada, Pathophysiological Function of Adrenomedullin and Proadrenomedullin N-Terminal Peptides in Adrenal Chromaffin Cells, Hypertension Research, vol.26, issue.Suppl, pp.71-78, 2003.
DOI : 10.1291/hypres.26.S71

M. Korner, B. Waser, and J. Reubi, High Expression of Neuropeptide Y Receptors in Tumors of the Human Adrenal Gland and Extra-Adrenal Paraganglia, Clinical Cancer Research, vol.10, issue.24, pp.8426-8433, 2004.
DOI : 10.1158/1078-0432.CCR-04-0821

S. Lamouche, N. Yamaguchi, D. Larhammar, and E. Salaneck, PACAP release from the canine adrenal gland in vivo: its functional role in severe hypotension, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol.260, issue.2, pp.588-597141, 2003.
DOI : 10.1139/y99-084
URL : http://ajpregu.physiology.org/content/ajpregu/284/2/R588.full.pdf

H. Lee, S. Hahm, C. Hsu, and L. Eiden, Pituitary Adenylate Cyclase-Activating Polypeptide Regulation of Vasoactive Intestinal Polypeptide Transcription Requires Ca2+ Influx and Activation of the Serine/Threonine Phosphatase Calcineurin, Journal of Neurochemistry, vol.18, issue.4, pp.1769-1772, 1999.
DOI : 10.1073/pnas.95.16.9602

E. Lee, M. Michalkiewicz, J. Kitlinska, I. Kalezic, H. Switalska et al., Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles, Journal of Clinical Investigation, vol.111, issue.12, pp.1853-1862, 2003.
DOI : 10.1172/JCI16929
URL : http://www.jci.org/articles/view/16929/files/pdf

T. Luke and T. Hexum, Tyrosine hydroxylase phosphorylation increases in response to ATP and neuropeptide Y co-stimulation of ERK2 phosphorylation, Pharmacological Research, vol.58, issue.1, pp.52-57, 2008.
DOI : 10.1016/j.phrs.2008.06.010

L. Malendowicz, M. Conconi, P. Parnigotto, and G. Nussdorfer, Endogenous adrenomedullin system regulates the growth of rat adrenocortical cells cultured in vitro, Regulatory Peptides, vol.112, issue.1-3, pp.27-31, 2003.
DOI : 10.1016/S0167-0115(03)00019-3

K. Masada, T. Nagayama, A. Hosokawa, M. Yoshida, M. Suzuki-kusaba et al., Effects of adrenomedullin and PAMP on adrenal catecholamine release in dogs, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol.266, issue.35, pp.1118-1124, 1999.
DOI : 10.1152/ajpcell.1994.266.5.C1432

G. Mazzocchi, G. Albertin, P. Andreis, G. Neri, L. Malendowicz et al., Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland, Peptides, vol.20, issue.12, pp.1479-1487, 1999.
DOI : 10.1016/S0196-9781(99)00159-X

S. Mckenzie and P. Marley, entry through store-operated channels to activate tyrosine hydroxylase in bovine chromaffin cells, European Journal of Neuroscience, vol.67, issue.9, pp.1485-1492, 2002.
DOI : 10.1055/s-2001-10634

Z. Miao, K. Luker, B. Summers, R. Berahovich, M. Bhojani et al., CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature, Proceedings of the National Academy of Sciences, vol.100, issue.20, pp.15735-15740, 2007.
DOI : 10.1073/pnas.1933744100

C. Moretti, C. Mammi, G. Frajese, S. Mariani, L. Gnessi et al., PACAP and Type I PACAP Receptors in Human Prostate Cancer Tissue, Annals of the New York Academy of Sciences, vol.1070, issue.1, pp.440-449, 2006.
DOI : 10.1196/annals.1317.059

M. Nakamura, B. Han, O. Nunobiki, and K. Kakudo, Adrenomedullin: A Tumor Progression Factor via Angiogenic Control, Current Cancer Drug Targets, vol.6, issue.7, pp.635-643, 2006.
DOI : 10.2174/156800906778742442

H. Nielsen, J. Hannibal, and J. Fahrenkrug, Prenatal Expression of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) in Autonomic and Sensory Ganglia and Spinal Cord of Rat Embryosa, Annals of the New York Academy of Sciences, vol.42, issue.1 VIP, PACAP, A, pp.533-536, 1998.
DOI : 10.1016/S0169-328X(96)00279-3

M. Hare and T. Schwartz, Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors, Cancer Res, vol.49, pp.7010-7014, 1989.

M. Payet, L. Bilodeau, L. Breault, A. Fournier, Y. L. Vaudry et al., Release from a cAMP-dependent Pool in Human Fetal Adrenal Gland Chromaffin Cells, Journal of Biological Chemistry, vol.245, issue.3, pp.1663-1670, 2003.
DOI : 10.1073/pnas.012608999

J. Pons, J. Kitlinska, J. H. Lee, E. Zukowska, and Z. , Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the ??-adrenergic system, Canadian Journal of Physiology and Pharmacology, vol.83, issue.2, pp.177-185, 2003.
DOI : 10.1161/01.RES.83.2.187

D. Renshaw, L. Thomson, G. Michael, M. Carroll, S. Kapas et al., Adrenomedullin Receptor Is Found Exclusively in Noradrenaline-Secreting Cells of the Rat Adrenal Medulla, Journal of Neurochemistry, vol.432, issue.4, pp.1766-1772, 2000.
DOI : 10.1016/S0014-5793(98)00828-X

J. Reubi, U. Laderach, B. Waser, J. Gebbers, P. Robberecht et al., Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin, Cancer Res, vol.60, pp.3105-3112, 2000.

P. Rose, J. Lynch, S. Frazier, S. Fisher, W. Chung et al., Molecular Genetic Analysis of a Human Neuropeptide Y Receptor, Journal of Biological Chemistry, vol.15, issue.6, pp.3622-3627, 1997.
DOI : 10.1038/nm0496-467

M. Ruscica, E. Dozio, M. Motta, and P. Magni, Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer, Peptides, vol.28, issue.2, pp.426-434, 2007.
DOI : 10.1016/j.peptides.2006.08.045

K. Shimoda, G. Shen, R. Pfeiffer, R. Mccomb, and H. Yang, Antiserum against neuropeptide Y enhances the nicotine-mediated release of catecholamines from cultured rat adrenal chromaffin cells, Neurochemistry International, vol.23, issue.1, pp.71-77, 1993.
DOI : 10.1016/0197-0186(93)90145-U

T. Shimosawa and T. Fujita, Adrenomedullin and its Related Peptide, Endocrine Journal, vol.52, issue.1, pp.1-10, 2005.
DOI : 10.1507/endocrj.52.1

R. Spinazzi, P. Andreis, and G. Nussdorfer, Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review), International Journal of Molecular Medicine, vol.15, pp.3-13, 2005.
DOI : 10.3892/ijmm.15.1.3

K. Takahashi, K. Totsune, O. Murakami, M. Sone, K. Itoi et al., Pituitary adenylate cyclase activating polypeptide (PACAP)-like immunoreactivity in pheochromocytomas, Peptides, vol.14, issue.2, pp.365-369, 1993.
DOI : 10.1016/0196-9781(93)90054-K

K. Tatemoto, M. Carlquist, and V. Mutt, Neuropeptide Y???a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide, Nature, vol.13, issue.5858, pp.659-660, 1982.
DOI : 10.1042/bj1190805f

E. Thouënnon, A. Elkahloun, J. Guillemot, A. Gimenez-roqueplo, J. Bertherat et al., Identification of Potential Gene Markers and Insights into the Pathophysiology of Pheochromocytoma Malignancy, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4865-4872, 2007.
DOI : 10.1210/jc.2007-1253

E. Thouënnon, A. Pierre, Y. Tanguy, J. Guillemot, D. Manecka et al., Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival, Endocrine Related Cancer, vol.17, issue.3, pp.637-651, 2010.
DOI : 10.1677/ERC-10-0109

C. Tonshoff, L. Hemmick, and M. Evinger, Pituitary adenylate cyclase activating polypeptide (PACAP) regulates expression of catecholamine biosynthetic enzyme genes in bovine adrenal chromaffin cells, Journal of Molecular Neuroscience, vol.83, issue.2, pp.127-140, 1997.
DOI : 10.1074/jbc.271.18.10545

B. Uzan, A. Villemin, J. Garel, and M. Cressent, Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway, Journal of Cellular Physiology, vol.15, issue.1, pp.122-128, 2008.
DOI : 10.4049/jimmunol.176.9.5548

D. Vaudry, A. Falluel-morel, S. Bourgault, M. Basille, D. Burel et al., Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery, Pharmacological Reviews, vol.61, issue.3, pp.283-357, 2009.
DOI : 10.1124/pr.109.001370
URL : http://pharmrev.aspetjournals.org/content/pharmrev/61/3/283.full.pdf

J. Wang, Y. Shiozawa, J. Wang, Y. Wang, Y. Jung et al., The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer, Journal of Biological Chemistry, vol.165, issue.7, pp.4283-4294, 2008.
DOI : 10.1074/jbc.M508234200

L. Yon, L. Breault, V. Contesse, G. Bellancourt, C. Delarue et al., Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation, J Clin Endocrinol Metab, vol.83, pp.1299-1305, 1998.

E. Zudaire, A. Martinez, and F. Cuttitta, Adrenomedullin and cancer, Regulatory Peptides, vol.112, issue.1-3, pp.175-183, 2003.
DOI : 10.1016/S0167-0115(03)00037-5

Z. Zukowska, J. Pons, E. Lee, and L. Li, Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?, Canadian Journal of Physiology and Pharmacology, vol.83, issue.2, pp.89-94, 2003.
DOI : 10.1161/01.RES.83.2.187